Veritas Capital, Elliott clinch $5.5 billion acquisition of Athenahealth: sources

Go back to Veritas Capital, Elliott clinch $5.5 billion acquisition of Athenahealth: sources

General Electric (GE) PT Lowered to $10 at Gordon Haskett

November 13, 2018 9:20 AM EST

Gordon Haskett analyst John Inch lowered the price target on General Electric (NYSE: GE) to $10.00 (from $11.00) while maintaining an Underperform rating. While GE has provided assurances that it retains plenty of opportunities through asset sales, Inch's calculations indicate most of these proceeds are already... More

General Electric (GE) PT Lowered to $10 at Credit Suisse

November 12, 2018 8:54 AM EST

Credit Suisse analyst, John Walsh, lowered the price target on General Electric (NYSE: GE) to $10.00 (from $12.00) while maintaining a Neutral rating. GE has declined 15% versus the XLI up 4% and the S&P 500 up 3%. Fallout from yield investors is adding pressure.

Investors are focused... More

athenahealth (ATHN) PT Lowered to $142 at KeyBanc Following 3Q

November 12, 2018 7:52 AM EST

KeyBanc analyst Donald Hooker lowered the price target on athenahealth (NASDAQ: ATHN) to $142.00 (from $170.00) while maintaining a Overweight rating following the company's 3Q. ATHN reported weak 3Q18 top-line metrics with soft bookings of only $38M (down ~34% y/y) and revenues lagging consensus ($330M vs.... More

Baird Downgrades athenahealth (ATHN) to Neutral Following Takeout Bid

November 12, 2018 4:21 AM EST

Baird analyst Matthew Gillmor downgraded athenahealth (NASDAQ: ATHN) from Outperform to Neutral with a price target of $135.00 (from $160.00).

The analyst steps aside following the expected takeout from Veritas and Elliot. He is not expecting a competing bid to emerge.

For an analyst... More